IRD
Opus Genetics, Inc. Common Stock
stockNASDAQ
At CloseNov 5, 2026 3:59:58 PM EST
4.01USD-6.316%(-0.27)1,481,279
After-hoursNov 5, 2026 4:41:30 PM EST
3.99USD-0.375%(-0.02)
IRD News
Opus Genetics completes dosing in gene therapy trial cohort · 
Investing.com
Opus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) · 
GlobeNewswire Inc.
Opus Genetics appoints chief scientific officer, operations head · Investing.com
Opus Genetics president Yerxa sells $117,364 in IRD stock · Investing.com
Opus Genetics COO Schachle reports $16,994 stock sale for taxes · Investing.com
Opus Genetics receives FDA clearance for RDH12-LCA gene therapy · Investing.com
Opus Genetics stock rating maintained at outperform by Citizens · Investing.com
Opus Genetics reports early trial results for gene therapies · Investing.com
Opus Genetics to Present at the Chardan Annual Healthcare Conference · GlobeNewswire Inc.